Bank Of America Corp Ocuphire Pharma, Inc. Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Ocuphire Pharma, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 213 shares of OCUP stock, worth $276. This represents 0.0% of its overall portfolio holdings.

Number of Shares

213

Holding current value

$276

% of portfolio

0.0%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.51 - $2.23 $321 - $474	213 New	213 $0
Q4 2023 Feb 14, 2024	BUY	$2.59 - $3.64 $69 - $98	27 New	27 $0
Q4 2022 Feb 10, 2023	BUY	$2.04 - $3.53 $93 - $162	46 New	46 $0

Others Institutions Holding OCUP

# of Institutions

Shares Held

2.74M

Call Options Held

Put Options Held

Vanguard Group Inc Valley Forge, PA

992K
Shares

$1.29 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

266K
Shares

$345,610
0.0% of portfolio
Rice Hall James & Associates, LLC

224K
Shares

$290,665
0.02% of portfolio
Richmond Brothers, Inc. Jackson, MI

191K
Shares

$248,695
0.6% of portfolio
Bridgeway Capital Management, LLC Houston, TX

164K
Shares

$212,863
0.01% of portfolio

View Full List

About Ocuphire Pharma, Inc.

Ticker OCUP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,579,800
Market Cap $26.8M
Description
Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...

More about OCUP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account